MATERIALS AND METHODS
Thyroid cancer incidence data for 1992 to 1995 were obtained from the Canadian Cancer Registry (CCR) which replaced the National Cancer Incidence Reporting System (NCIRS) of Statistics Canada in 1992. Data for the province of Quebec were excluded because improved reporting procedures were not implemented there until 1981. The information regarding the CCR and the quality of Canadian cancer incidence data has been well documented (Band et al, 1993; Gaudette and Lee, 1997) . In general, the cancer registry data included in this study are comparable and reliable, and 90% of thyroid cancers were pathologically confirmed in the period 1969-1973, and 95% in the period 1984-1988 (Band et al, 1993) .
Information on histological classification of thyroid cancer was not consistently recorded by all provinces and territories in Canada until 1983, although Ontario, Saskatchewan and British Colombia collected such data even in earlier decades. The three provincial cancer registries used the Systematized Nomenclature of Pathology for histological classification until 1978, and all the records have been subsequently converted to the International Classification of Disease for Oncology (ICD-O) . Based on the ICD-O first and second editions, thyroid cancer is coded as topography site codes 193 and C73, respectively. In this study, cases were subdivided into 3 broad histological groups: papillary, follicular and other specified or not otherwise specified (NOS) carcinomas.
We first contrasted average 3-year age-adjusted rates for the period 1970-72 with that for 1994-96 for both sexes. We then compared the rates in 4 broad age groups, i.e., 10-24, 25-44, Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects 45-64 and 65-84 years. Secular trends in the incidence of thyroid cancer were evaluated through Poisson regression models using annual rates for all ages as well as for the described broad age groups. Correspondingly, the average annual percent changes (AAPC) during the study period were derived from the regression coefficients of those models. All age-adjusted incidence rates were calculated using direct standardization with the World Standard Population as the standard (Parkin et al, 1992) .
In analyses integrating age at diagnosis, time period of diagnosis and birth cohort, age was grouped into 5-year intervals (15-19 years to 80-84 years). The period of diagnosis covered five equal 5-year intervals from 1972 to 1996. Corresponding to these age groups and time periods, a total of 18 overlapping 10-year birth cohorts (1887-1896 to 1972-1981, identified by the central year of birth from 1892 to 1977) were available for modelling of the incidence data.
A Poisson regression model was used to estimate the age, period and cohort effects. The model assumes that the number of cancer cases follows a Poisson distribution and the incidence rates are a multiplicative function of the included model parameters, making the logarithm of the rates an additive function of the parameters (Clayton and Schifflers, 1987a Schifflers, , 1987b Holford, 1991 Holford, , 1992 . For example, the form of the age-period-cohort (APC) model was given by
where d ij denotes the number of the incident cases in the ith age group and jth period; p ij , the population at risk in the ith age group and jth period; α i the effect of the ith age group; β j , the effect of the jth period category; and γ k , the effect of the kth cohort category (k = I -i + j when i = 1,2,...,I). Inherent in the three-factor APC model is the non-identifiability problem: parameters for age, period and cohort are not uniquely estimable because of the exact linear dependence of the regression variables (cohort = period -age) (Holford, 1992; Tarone and Chu, 1996) . Although several methods for dealing with the non-identifiability problem have been proposed, there is no consensus in the literature as to which method is optimal. In our study, 3-factor APC models for the data were fitted by constraining the regression coefficients for the two extreme cohorts as zero, an approach commonly used in several previous studies (Tarone and Chu, 1996; Shahpar and Li, 1999; O'Callaghan et al, 2000) . To compare the curvatures or the departure of the time trends in incidence between females and males in a single model (using an additional variable to define the gender), we introduced interaction terms between sex and the 3 time factors into the above general model (Holford, 1992; Liu et al, 2000) . Changes in age, period and cohort effects were estimated along with the interaction terms.
Parameters of the models were estimated by means of the maximum likelihood method with SAS procedure GENMOD (release 6.12, SAS Institute Inc, Cary, NC 1997). The goodnessof-fit of models was evaluated using the deviance, defined to be twice the difference between the maximum achievable log likelihood and the log likelihood at the maximum likelihood estimates of the regression parameters. Specific effects (e.g., period effects) were tested by comparing the difference in deviance between models with and without a term for the effect.
RESULTS
A total of 18 804 incident cases of thyroid cancer were registered in Canada excluding Quebec between 1970 and 1996. Of these, 13 975 (74.3%) were diagnosed in women and 4 829 (25.7%) in men. According to data for provinces of Ontario, Saskatchewan and British Columbia, 60% of 13 712 incident cases of thyroid cancer were classified as papillary carcinomas, 15% as follicular carcinoma and 25% as NOS.
The overall age-adjusted rate among females and males increased substantially, from 3.5 and 1.1 per 100 000 population in 1970-72 to 6.7 and 2.2 per 100 000 population in 1994-96, respectively. The increasing trend among females appears to be more marked than that among males especially since the early 1980s (Figure 1 ), mostly due to an increase in papillary carcinoma which more than tripled between 1970-72 and 1994-96, from 1.4 to 5.4 per 100 000 among females and from 0.4 to 1.4 per 100 000 among males. Other types remained more or less stable (data available upon request).
The overall rate of increase in thyroid cancer among females was only slightly higher than that among males (AAPC: 3.5% vs 3.2%). However, the age-specific patterns of change were different across genders. For example, reproductive age-group women (age 25-44) experienced the most rapid increase (AAPC = 3.7%), while elderly women (age 65-84) had only a slight increase (AAPC = 0.7%) over the study period. In contrast, the differences in AAPCs between age groups were relatively smaller among men (Table 1) .
The age-specific incidence rates by birth cohort are plotted in Figures 2 and 3 for females and males, respectively. The incidence showed an appreciable increase since the birth cohort of 1922 for both women and men, although the birth cohort effect was more evident among women. A high rate plateau was observed among those aged 30 to 64 years for women, while the incidence rates for men increased by age group, to the highest among the elderly aged 65 to 79 years (Figures 2 and 3) .
Age-period-cohort models were fitted to the data for 1972 through 1996 for females and males separately. Table 2 summarizes the results of the modelling. Modelling of the data for females suggested that a full age-period-cohort model provided a significant improvement over either the age-cohort model or ageperiod model. The birth cohort effect was more pronounced than the period effect in terms of the ratio of the deviance and degrees of freedom. The full model was thus considered satisfactory for the time trends in thyroid cancer incidence among females. On the other hand, the age-cohort model fits the data for males well. Neither the age-period model nor the full age-period-cohort model achieved a better fit. Therefore, the best-fitting model of the data for males showed a significant birth cohort effect in addition to an age effect.
All sex-curvature interactions with age, time period and birth cohort were statistically significant (P < 0.05 or P < 0.01), indicating that time trends among men differ significantly from women in terms of age at diagnosis, time period and birth cohort curvature effects. The contrast between the 'unique' trend lines obtained from fitting an age-period-cohort model showed different patterns between genders. For example, while the risk began to decrease around the age 55 among women, it instead increased sharply among men. On the other hand, the incidence trend rose steadily since the birth cohort of 1932 among women, while no clear changes were observed across the birth cohorts among men (Figure 4 ).
DISCUSSION
Our results show that the overall age-adjusted incidence rates of thyroid cancer have been increasing in Canada among both females and males. The increase almost entirely comes from papillary carcinoma of the thyroid, with the greatest increase among young and middle-age women. This observation is similar to reports from the United States (Spitz et al, 1988; Zheng et al, 1996) , Sweden (Pettersson et al, 1991) , Norway (Akslen et al, 1993) and Britain (Dos Santos Silva and Swerdlow, 1993) . Ageperiod-cohort modelling further shows that both birth cohort and period effects are responsible for the observed trends among females, while a birth cohort effect is the main determinant for the observed increase among males. More importantly, different sex patterns in terms of age, period and birth cohort curvatures were demonstrated, suggesting aetiologic heterogeneity between women and men in the pathogenesis of the disease (Figure 4) .
Our results suggest that birth cohort effects are the major determinants of the observed trends in this population. Previous epidemiological studies have indicated that prior radiotherapy in childhood increases the risk of thyroid cancer (Boice, 1986; Ron et al, 1987; Spitz et al, 1988; Dos Santos Silva and Swerdlow, 1993; Inskip et al, 1995; Zheng et al, 1996; Mao et al, in press ). Shore (1992) estimated that the risk of thyroid cancer associated with juvenile external irradiation is about 2.6 excess cancer/10 000 persons/year/gray. In Canada, ionizing radiation was used to treat children with benign conditions of the head and neck (e.g., enlarged thymus, tonsillitis and adenoids) between the 1930s and the 1960s. A population-based case-control study conducted in Connecticut, USA estimated that 9% of the disease in the population might be attributable to the prior radiotherapy to the head and neck in infancy (Ron et al, 1987) .
Ionizing radiation is a main well-established risk factor for thyroid cancer (Shore et al, 1985; Franceschi and Vecchia, 1994; Ron, 1995) . For the general population, diagnostic radiology may be the main source of exposure to ionizing radiation, and an increased risk associated with diagnostic X-rays is also biologically plausible (Shore et al, 1985; Franceschi and Vecchia, 1994) . Furthermore, the thyroid gland may be included in the radiation field when either the upper body or the chest is exposed to X-rays. The susceptibility to radiation-induced thyroid cancer is the greatest for examinations occurring in childhood and adolescence (Boice, 1986; Ron et al, 1987; Spitz et al, 1988) . Thus, our results suggest that the increasing trends in thyroid cancer incidence in Canada could be associated with change in radiation exposure in childhood and adolescence; nevertheless, the increases observed are larger than can be explained by the levels associated with current diagnostic procedures. A large prospective follow-up study (Inskip et al, 1995) found no tendency for case subjects to have experienced more X-ray procedures associated with a higher radiation dose to the thyroid gland. Diagnostic radiation also cannot satisfactorily explain the increases in the incidence observed only among women aged 25-64 years and the continued increase among recent birth cohorts.
Because of the marked female to male excess of welldifferentiated thyroid cancers observed, a number of epidemiological studies have examined possible associations between hormones and other reproductive factors and the risk of thyroid cancer (Preston-Martin et al, 1987; Levi et al, 1993; Galanti et al, 1995; Paoff et al, 1995; Mack et al, 1999) . Unlike the pattern observed for breast cancer, pregnancy and early menopause appear to enhance the risk of thyroid cancer (Preston-Martin et al, 1987; Levi et al, 1993) . Furthermore, the association is more pronounced for the papillary type than the follicular type (Levi et al, 1993; Galanti et al, 1995) . Among reproductive exposures, miscarriage or abortion, particularly in the first pregnancy is the most consistent risk factor (Preston-Martin et al, 1987; Levi et al, 1993; Ron, 1995) . A recent pooled analysis (Negri et al, 1999) of original data from 14 case-control studies of thyroid cancer showed that there is a limited association with overall menstrual and reproductive factors, while miscarriage of the first pregnancy posts a high risk for developing papillary carcinoma (e.g., pooled OR 1.7 (95% CI 1.1-2.7)). In Canada, the therapeutic abortion rate for reproductive age women increased from 9.7 per 1000 in 1974 to 14.7 per 1000 in 1994, with the highest rates among young women aged 18-29 years (Health Statistics Division, 1996) . However, the controversial findings regarding hormones and reproductive factors deserve further research in which confounders are better controlled.
More intensive diagnostic activity is another possible explanation for the increasing trends, given increased use of more sophisticated diagnostic methods (e.g., fine-needle biopsy, radio-isotope thyroid scanning) together with broader indications for the surgical removal of solitary nodules (Pettersson et al, 1991; Akslen, 1993; Dos Santos Silva and Swerdlow, 1993; Ron, 1995) . Since papillary carcinomas have an indolent clinical course, intensive diagnostic activity may be leading to the discovery of occult papillary carcinomas. Corresponding to the rapid development in advanced histopathological techniques since the late 1970s, an increasing numbers of asymptomatic tumours of the thyroid may have been detected. In addition, histopathological misclassification cannot be ruled out in our data, as the introduction of new WHO histological criteria in 1974 had some impact on the changing temporal trends by histological subtype. It is likely, therefore, that an early detection artefact identified as a period effect in this study has played a role as well. Since that effect is only statistically significant in women, one may readily speculate that doctors may have increased their use of new diagnostic methods particularly in young patients and females. Nevertheless, the increase in papillary carcinoma and the underlying birth cohort effects cannot be explained entirely by increasing diagnosis of occult carcinomas or changes in classification.
Other risk factors such as radioactive fallout (Akslen et al, 1993; Dos Santos Silva and Swerdlow, 1993) , iodine deficiency or iodine excess, endemic goiter (Pettersson et al, 1991; Franceschi and La Vecchia, 1994) and certain dietary factors appear to be unlikely to explain the overall temporal trend and the birth cohort pattern observed in this population. Since the causes of most thyroid cancer have yet to be discovered, the effect of these risk factors warrants further investigation. 1 9 7 2 − 7 6 1 9 8 2 − 8 6 1 9 9 2 − 9 6 1 8 9 7 1 9 0 7 1 9 1 7 1 9 2 7 1 9 3 7
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Figure 4
Age, period and cohort effects on thyroid cancer incidence for females (solid line) and males (dashed line) estimated by a three-factor model with interaction terms for sex. The values for the first and last cohorts are not displayed (Tarone and Chu, 1996) In conclusion, the steady increasing trends in the incidence of thyroid cancer during recent decades appears to be real. No single hypothesis regarding the associated risk factors can explain the rapidly increasing incidence. The birth cohort pattern observed for thyroid cancer incidence in the Canadian population suggests that the hypothesis that radiation exposure in childhood and adolescence is responsible for increasing risk of developing papillary carcinoma should be further investigated. Changes in female hormones and reproductive factors, particularly increased abortions or miscarriages, may partially explain the rapidly increased incidence among young and middle-aged women. Improved early detection may also have played a role, and should be further investigated. Other unrecognized aetiologic factors remain to be identified. The differential age, period and cohort effects provide clues to aetiologic heterogeneity in the pathogenesis of thyroid cancer between females and males.
